Some costs for breast implant revision surgery may be covered by your surgeon, depending on the reason for revision. “Generally, if the doctor feels the result is below their expectations, they will often cover much or all of the cost,” says Seattle plastic surgeon Dr. Richard P. Rand in a RealSelf Q&A. “However, if the problem is something about your body, like capsular contracture or wrinkling and rippling above the muscle, it is reasonable that charges should apply as this is no fault of the doctor.”
In 1999, the Institute of Medicine published the Safety of Silicone Breast Implants (1999) study that reported no evidence that saline-filled and silicone-gel filled breast implant devices caused systemic health problems; that their use posed no new health or safety risks; and that local complications are “the primary safety issue with silicone breast implants”, in distinguishing among routine and local medical complications and systemic health concerns.”
Unfortunately, as time goes on it is often difficult for patients to remember the specifics of the type of breast augmentation surgery and implants that they had. Your are not alone! The easiest way to determine what type of implant you had is to request a copy of the operative report from either the hospital, surgery center or your surgeon's office. The implant specifics are recorded on this document. Your office record also includes this information. If it has been over ten years since your procedure, sometimes these records are no longer available. Ultrasound or MRI can help to answer this question but it is an expensive way to solve the mystery and not an indication for these procedures. If you registered your implants with the manufacturer at the time of surgery, the company will have a record of this information. Fortunately, this inforation is not absoltely critical to your health unless you are having a problem with your implants. Your surgeon can often develop a reasonable treatment plan even without this information. I would strongly recommend that you register your implants and purchase the affordable insurance program if you have surgery again. These programs are helpful in storing vital information regarding your implant type, size, filler, model and lot number. Should there be a recall or long term problem requiring additional surgery, this information is readily available. There is often also some fiancial support to offset costs. Investigate the options available by contacting your surgeon or the implant manufacturer's websites.
This includes the cost of the implants, which ranges from $1,000 to $1,300 as well as a facility fee of $800 to $1,200, an anesthesia fee of $600 to $800 and the surgeon's fee that averages $4,005 for silicone-gel filled implants and $3,583 for saline implants. Patients in the western United States can expect to pay the highest average surgeon's fee of about $3,949, while patients in the south central part of the country generally pay lower fees with an average of $2,739.
The current lifetime risk of BIA-ALCL in the U.S. is unknown, but estimates have ranged between estimated to be between 1 in 70,000 to 1 in 500,000 women with breast implants according to MD Anderson. Certain geographic locations have demonstrated variable risks. For instance, a December 2016 update from the Therapeutic Goods Administration of Australia and New Zealand reported a risk of 1:1,000 to 1:10,000 for textured implants.". To date (2017), there has not been a case of BIAL reported where the patient had only implantation of smooth shell breast implants or a textured tissue expander that was exchanged for a smooth implant. The paucity of cases reported in Asian populations has raised the possibility that there may be a range of genetic susceptibility to the phenomena, or alternatively merely reflect differences in how cases are identified and reported.
The FDA has identified that breast implants may be associated with a rare form of cancer called anaplastic large-cell lymphoma, believed to be associated with chronic bacterial inflammation. Similar ALCL phenomena have been seen with other types of medical implants including vascular access ports, orthopedic hip implants, and jaw (TMJ) implants. As of February 1, 2017, the FDA has received a total of 359 medical device reports of breast-implant-associated ALCL (BIALCL), including 9 deaths. Most cases of breast implant-associated ALCL had implants in for many years prior to the condition, and are usually treated successfully by simple removal of the implant and the capsule surrounding the implant without the need for chemotherapy if no evidence of systemic disease exists. If women with implants present with delayed swelling or fluid collection, cytologic studies and test for a marker "CD30" are suggested. The American Society of Plastic Surgery (ASPS) states, "CD30 is the main diagnostic test that must be performed on the seroma fluid as routine pathology or H&E staining can frequently miss the diagnosis."  Diagnosis and treatment of breast implant associated ALCL now follows standardized guidelines established by the National Comprehensive Cancer Network.